Development and Initial Application of a Combined Exercise and Psychological Intervention Program for Patients After Esophagectomy
Launched by MENGMENG YUAN · Apr 10, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new program called "Recovery For EC," designed to help patients who have undergone surgery for esophageal cancer. The program combines exercise and psychological support to address both the physical and emotional challenges that many patients face during recovery. Research has shown that while exercise and psychological help can be beneficial, existing programs often lack a comprehensive approach. This trial aims to develop a more effective intervention by focusing on symptom management and recovery strategies tailored to individual needs.
To participate in the trial, individuals must be at least 18 years old, have a confirmed diagnosis of esophageal cancer, and be undergoing surgical treatment. Eligible patients should be able to communicate effectively and understand their condition. Those with serious health issues that prevent them from participating or those involved in other studies will not be included. Participants can expect to engage in the Recovery For EC program, which will help them monitor their recovery and provide healthcare professionals with useful information to personalize their rehabilitation. This trial is not yet recruiting, but it holds promise for improving recovery outcomes for esophageal cancer patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Confirmed diagnosis of esophageal cancer by pathological biopsy.
- • 2. Undergoing surgical treatment.
- • 3. Age ≥ 18 years old.
- • 4. The patient is able to communicate effectively in language.
- • 5. The patient is fully aware of their condition and willingly participates in the investigation.
- Exclusion Criteria:
- • 1. Patients with consciousness disorders.
- • 2. Patients with severe physical illnesses who are unable to cooperate with the investigation.
- • 3. Participation in other studies.
About Mengmeng Yuan
Mengmeng Yuan is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and ethical standards, Mengmeng Yuan collaborates with healthcare professionals and research institutions to design and execute clinical trials that address unmet medical needs. By leveraging cutting-edge technology and a patient-centric approach, the organization aims to expedite the development of safe and effective treatments, ultimately contributing to the enhancement of global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hefei, Anhui, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported